Analyst Ratings for Esperion Therapeutics (ESPR)
ESPR Rating Summary
ESPR Price Target Summary
- Highest: $5.00 (Citizens)
- Lowest: $1.78 (BofA Securities)
- Average: $3.31
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$3.31 (+4.9%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
$3.31 (+4.9%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/4/2026 | Needham | Serge Belanger | Downgrade | Hold (Buy) |
N/A (N/A) |
3.11 (3.15) |
1.29% | Details |
| 5/1/2026 | Jefferies | Dennis Ding | Downgrade | Hold (Buy) |
3.28 (5.00) |
2.00 (3.15) |
57.5% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
